Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pluristem Therapeutics Inc (NASDAQ:PSTI)

2.37
Delayed Data
As of Jul 30
 -0.04 / -1.66%
Today’s Change
2.27
Today|||52-Week Range
3.78
-5.20%
Year-to-Date

Today’s Trading

Previous close2.41
Today’s open2.43
Day’s range2.33 - 2.45
Volume570,139
Average volume (3 months)187,960
Market cap$189.2M
Dividend yield--
Data as of 3:59pm ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)-10.53%
Earnings growth (this year)+14.88%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-44.18%
P/E ratioNM
Price/Sales418.96
Price/Book2.66

Competitors

 Today’s
change
Today’s
% change
FATEFate Therapeutics In...-0.05-0.70%
CYTRCytRx Corp-0.10-3.50%
ASTAsterias Biotherapeu...-0.04-0.81%
ENZYEnzymotec Ltd+0.73+9.38%
Data as of 4:01pm ET, 07/30/2015

Financials

Next reporting dateSeptember 11, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$379.0K
Annual profit (last year)-$26.9M
Net profit margin-7,106.07%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Zami Aberman
President &
Chief Operating Officer
Yaky Yanay
Corporate headquarters
Haifa, Haifa

Forecasts